Skye Bioscience, Inc. (SKYE)
0.649
-0.01
(-0.95%)
USD |
NASDAQ |
Mar 20, 16:00
0.6363
-0.01
(-1.96%)
After-Hours: 20:00
Skye Bioscience Total Liabilities (Quarterly) : 8.290M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Halozyme Therapeutics, Inc. | 2.665B |
| Merck & Co., Inc. | 84.20B |
| SIGA Technologies, Inc. | 21.15M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 28.31M |
| Shareholders Equity (Quarterly) | 20.02M |
| Debt to Equity Ratio | 0.0137 |
| Current Ratio | 3.302 |
| Net Debt Paydown Yield | -0.07% |